Storys zum Thema Medikament

Hovione

Hovione invests $170 million in new capacity and capabilities

Milan (ots/PRNewswire) - Hovione, the global leader in spray drying and particle engineering, today announced that it is expanding its industrial facilities around the world to support its ambitious growth objectives. The company has been on an expansion track since 2016 in Portugal, Ireland and New Jersey with the aim of continuing to increase its capacity and capabilities to address customer needs. The announcement of a ...

Essence SmartCare

Essence SmartCare Wins CES 2022 Innovation Award for VitalOn Telehealth Platform

Herzliya, Israel (ots/PRNewswire) - System Recognized for Comprehensive Remote Patient Monitoring Capabilities and Chronic Conditions Management Addressing Wide Range of Healthcare Needs Essence SmartCare, a leader in IoT-based remote care solutions, part of Essence Group, today announced that it has been named a CES® 2022 Innovation Awards Honoree for the VitalOn ...

Genomics England; Queen Mary University of London (QMUL)

Whole genome sequencing improves diagnosis of rare diseases and shortens diagnostic journeys for patients, according to world first study

London (ots/PRNewswire) - NB: SCIENCE MEDIA BRIEFING TAKING PLACE 14:00 GMT 9TH NOVEMBER 2021 - whole genome sequencing proved to be a better way to diagnose rare diseases than usual genomic testing methods - whole genome sequencing led to new rare disease diagnoses for NHS patients in some cases ending decades-long ...

IDEA Pharma

Pfizer tops the CNS Summit Innovation Index

London (ots/PRNewswire) - The fifth annual ranking of digital, R&D and commercial partnership innovation in global pharma The fifth annual CNS Summit Innovation Index, compiled by IDEA Pharma, sees Pfizer top the industry. Released at the CNS Summit in Boston, MA, the CNS Summit Innovation Index examines which drug makers are leveraging innovation in three spheres: clinical development which sets the stage for future ...

Debiopharm International SA

Swiss-based Debiopharm co-invests in the future of cell therapies on a chip through the latest $25 million Series A round for Mekonos

Lausanne, Switzerland - San Francisco (ots) - Funding to accelerate the development of Mekonos’ System on a Chip (SoC), expand commercial partnerships Debiopharm (www.debiopharm.com), a Swiss biopharmaceutical company, announced today having invested $4M inMekonos, a biotech company building the future of cell ...

MC2 Therapeutics; EPI Health

EPI Health and MC2 Therapeutics Announce Wynzora® Cream (calcipotriene and betamethasone dipropionate w/w 0.005%/0.064%) now covered on Express Scripts National Preferred Formulary

Charleston, S.c. and Copenhagen, Denmark (ots/PRNewswire) - Wynzora® Cream (calcipotriene and betamethasone dipropionate, w/w 0.005%/0.064%) for once-daily topical treatment of plaque psoriasis in adults 18 years of age or older. EPI Health, LLC, a specialty pharmaceutical company committed to delivering innovative ...

Novo Nordisk

Wegovy(TM) Demonstrated Significant and Sustained Weight Loss in Two-Year Study in Adults With Obesity

Bagsværd, Denmark (ots/PRNewswire) - - The STEP 5 trial demonstrated an average weight loss of 15.2% with Wegovy(TM) at 104-weeks when used with a reduced calorie meal plan and increased physical activity vs. 2.6% with placebo - The trial also showed that 77.1% of study participants who received Wegovy(TM) lost at ...

ZENTIVA Pharma GmbH

Zentiva Advances Pharmaceutical Research Through ORBIS Project

Prague (ots/PRNewswire) - One of the missions that Zentiva has consistently pursued is to connect Academia and the Pharmaceutical Industry to accelerate drug development innovation and meet the unmet needs of the patients. Our company is pleased to resume the scientific exchange program as part of the ORBIS project, which was created within the largest EU grant programs HORIZON 2020, to connect European and American ...

Abcam; Nautilus Biotechnology, Inc.

As an element of Nautilus' overall reagent development and sourcing strategy, the partnership aims to accelerate research and development, and provide customers with access to Abcam's antibody development technology and expertise

Seattle and Cambridge, England (ots/PRNewswire) - Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or "Nautilus"), a company pioneering a single-molecule protein analysis platform for quantifying the proteome, and Abcam (AIM:ABC; NASDAQ:ABCM), a global innovator in life sciences research tools, today announced a ...

Schweizerischer Nationalfonds / Fonds national suisse

The ethical dilemma of forensic therapy

Bern (ots) - Therapy and reporting to the judiciary - psychiatric professionals in prison have a conflict of loyalties. How do they deal with it? The treatment of people for whom a therapeutic measure has been ordered by the court creates a conflict of loyalties for medical professionals. A study(*) supported by the SNSF reveals how they deal with this in practice. Approximately one thousand people in Switzerland are ...

World Stroke Day

World Stroke Day: Global survey reveals only 35% hospitals worldwide provide essential stroke treatment

Geneva (ots/PRNewswire) - On World Stroke Day, 29 October, the World Stroke Organization (WSO) is calling for urgent action after a survey by the WSO and the World Health Organization (WHO) found that only 35% of hospitals worldwide provide essential clot-busting medicine tissue plasminogen activator (tPA), despite ...

Roche Diabetes Care

Roche and the Zur Rose Group announce collaboration to offer innovative health journeys for people living with diabetes

Basel, Switzerland (ots/PRNewswire) - - Roche, a world leader in integrated Personalised Diabetes Management, and the Zur Rose Group, provider of a European digital healthcare ecosystem, announce their collaboration to improve everyday therapy management and better address the needs of 60 million people living with ...

Roche Diabetes Care

Roche and the Zur Rose Group announce collaboration to offer innovative health journeys for people living with diabetes

Basel (ots) - - Roche, a world leader in integrated Personalised Diabetes Management, and the Zur Rose Group, provider of a European digital healthcare ecosystem, announce their collaboration to improve everyday therapy management and better address the needs of 60 million people living with diabetes in Europe [1] - ...

The International Osteoporosis Foundation (IOF)

Action for bone health is needed now more than ever, urges IOF

Debiopharm International SA

CARB-X FUNDS THE 3RD ROUND OF DEBIOPHARM’S TARGETED ANTIBIOTIC PROGRAM TO COMBAT RESISTANT N. GONORRHOEAE INFECTIONS

Lausanne, Switzerland / Boston, USA (ots) - Debiopharm (www.debiopharm.com), a Swiss-based global biopharmaceutical company announced today having been awarded the third phase funding to advance the development of its antibiotic program, Debio 1453, by the Combating Antibiotic-Resistant Bacteria Biopharmaceutical ...

Seibersdorf Labor GmbH; Isotopia Molecular Imaging

Isotopia Molecular Imaging and Seibersdorf Labor GmbH Announce Production Agreement for 177Lu n.c.a.

Tel Aviv, Israel and Vienna, Austria (ots/PRNewswire) - Isotopia Molecular Imaging and Seibersdorf Labor are pleased to announce that they have entered into an agreement for the production of no-carrier-added Lutetium-177, a critical medical radioisotope used in the manufacturing of radiopharmaceuticals for ...

Schweizerischer Nationalfonds / Fonds national suisse

SNSF opposes initiative to ban animal and human experimentation

Bern, 14.10.2021 (ots) - The Swiss National Science Foundation (SNSF) strives consistently and continuously to improve the quality of research. A ban on animal and human experiments would massively restrict the opportunity to gain knowledge and adversely affect Switzerland as a research hub. On 13 February 2022, the Swiss electorate will vote on the initiative to ban animal and human experiments. Acceptance of the ...

Micreos

Micreos appoints Matt Regan as CEO of its Pharmaceutical business

The Hague, Netherlands (ots/PRNewswire) - Dutch biotechnology company Micreos has recruited Matt Regan as CEO of its new Pharmaceutical business that will be based in Switzerland. Following rapid growth, Micreos is preparing to spin-out its Pharmaceutical business into a separate company as per January 2022 to directly access the capital markets. This will help to fund pipeline development to progress its highly ...

Novaliq GmbH

Novaliq Receives EU Quality Management Certificate According To New Medical Device Regulation (MDR)

Heidelberg, Germany (ots/PRNewswire) - Novaliq, a biopharmaceutical company focusing on first- and best-in-class ocular therapeutics based on the unique EyeSol® water-free technology, today announced that it has implemented and applies a quality management system in accordance with Annex IX, Chapter I of the EU ...

Fresenius Kabi Deutschland GmbH

Fresenius Kabi at ESPEN Virtual Congress 2021: EuroPN Study will provide new clinical data on critical care nutrition

Bad Homburg, Germany (ots/PRNewswire) - Real-world-data on the medical nutrition practice in Intensive Care Units (ICU) for critically ill patients is limited so far. To close this knowledge gap, Fresenius Kabi started EuroPN Study in 2019 in eleven European countries with around 100 participating hospitals[1]. At ...

Debiopharm International SA

DEBIOPHARM & DEXA MEDICA LAUNCH TRIPTORELIN COLLABORATION TO BRING NEW HOPE TO WOMEN WITH ENDOMETRIOSIS

Lausanne, Switzerland – Tangerang, Indonesia (ots) - Debiopharm (www.debiopharm.com), a Swiss-based, global biopharmaceutical company, and Dexa Medica, a leading Indonesian pharmaceutical company, today announced the Indonesian launch of triptorelin for the treatment of women with gynecological disorders, ...

Norgine GmbH

Norgine B.V. celebrates 30 years of the bowel preparations used in colonoscopy to help prevent and diagnose gastrointestinal diseases, including colorectal cancer

Amsterdam (ots/PRNewswire) - NORGINE B.V. (Norgine), a leading European specialist pharmaceutical company, celebrates its 30th anniversary of continuous innovation in bowel preparations at the United European Gastroenterology (UEG) Week Virtual. Bowel preparations are used in colonoscopy to prevent and diagnose ...

Debiopharm International SA

DEBIOPHARM ENCOURAGES BREAKTHROUGH CANCER RESEARCH IN JAPAN THROUGH ITS COMPETITIVE JCA MAUVERNAY AWARD

Lausanne, Switzerland (ots) - Debiopharm (www.debiopharm.com), a Swiss-based global biopharmaceutical company, today announced the two winners of the 17th annual JCA Mauvernay Award for breakthrough Japanese oncology research projects in 2 categories: Innovative and/or Disruptive Research –Dr. Shumpei Ishikawa and ...

Micreos

Micreos secures EUR32 million for its endolysin-based platform as sustainable alternative to antibiotics

The Hague, The Netherlands (ots/PRNewswire) - Dutch biotechnology company Micreos announced it has secured another EUR32 million in funding to further develop its endolysin platform technology, based on targeted killing of only unwanted bacteria. This funding round will help Micreos accelerate its clinical ...